baber/WOPTO huggingface dataset:
Patent NZ-234417-A (NZ)
Title: Pharmaceutical compositions and kits used to treat prostate cancer containing a non-adrenal inhibitor and an antiandrogen
Inventor: LABRIE FERNAND
IPC: A61K31/57
Filed: 1990-07-09
Abstract: A method of treatment of androgen-related diseases such as prostate cancer in susceptible male animals, including humans, comprises administering novel antiandrogens and/or novel sex steroid biosynthesis inhibitors as part of a combination therapy. Sex steroid biosynthesis inhibitors, especially those capable of inhibiting conversion of dehydroepiandrosterone (DHEA) or 4-androstenedione ( DELTA 4-dione) to natural sex steroida (and testosterone into dihydrotestosterone) in peripheral tissues, are used in combination with antiandrogens usually after blockade of testicular hormonal secretions. Antiestrogens can also be part of the combination therapy. Pharmaceutical compositions and two, three, four and five component kits are useful for such combination treatment.
Patent NZ-237315-A (NZ)
Title: High temperature induction furnace with susceptor located within charge
Inventor: CONOCHIE DAVID STEWART
IPC: H05B6/22
Filed: 1991-03-05
Abstract: A furnace configuration is disclosed which is suitable for scale-up of heat transfer limited processes performed at high temperatures, e.g. carbothermic reduction of transition metal or rare earth oxides. The furnace is inductively heated by external insulated coils (3) and the susceptor (2), preferably graphite rings, is placed within the charge (1) away from the outer surfaces of the charge (1). Consequently heat is transferred to the charge (1) in three dimensions and the process approaches completion before the insulation (4) is subjected to high temperatures. As a result of this three dimensional heat transfer, larger furnaces are possible within the heat transfer constraints of these high temperature processes and higher yields are obtained.
Patent NZ-241249-A (NZ)
Title: 7-((2-aminothiazol-4-yl) oximinoacetylamino-3-cephem-4-carboxylic acid derivatives substituted at the 3-position by thiazolothio or pyridinothiazolothio groups; pharmaceutical compositions; intermediates
Inventor: TERNANSKY ROBERT JOHN
IPC: C07D501/59
Filed: 1992-01-08
Abstract: An antibacterial compound of the formula <CHEM> wherein R is hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, or C1-C6 haloalkyl; A and A min  are independently hydrogen, C1-C6 alkyl, nitro, amino, C1-C6 alkoxy, a 5-6 membered heterocycle containing nitrogen or sulfur, or phenyl; or A and A min taken together form a group of the formulae <CHEM> wherein X is hydrogen, halo, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkoxycarbonyl, amino, nitro, or carboxy; and Y is nitrogen or carbon; or a pharmaceutically acceptable salt thereof.
Patent NZ-249113-A (NZ)
Title: Recombinant dna encoding tgf-b, its production and pharmaceutical compositions thereof
Inventor: NEIDHARDT HELGE
IPC: C07K14/655
Filed: 1993-02-12
Abstract: The invention provides DNA sequences encoding novel members of the TGF- beta  family of proteins. The TGF- beta  family comprises proteins which function as growth and/or differentiation factors and which are useful in medical applications. Accordingly, the invention also describes the isolation of the above-mentioned DNA sequences, the expression of the encoded proteins, the production of said proteins and pharmaceutical compositions containing said proteins.
Patent NZ-269808-A (NZ)
Title: Pharmaceutical composition for the solubilisation of a poorly soluble active agent comprising polyglycerol and/or sorbitan fatty acid ester, a triglyceride and a non ionic surfactant
Inventor: POSANSKI ULRICH
IPC: A61K47/14
Filed: 1994-07-08
Abstract: Pharmaceutical prepn. comprises () a pharmaceutically active agent which is sparingly soluble in water; and (b) a carrier compsn. comprising (i) at least one polyglycerine fatty acid ester and/or at least one sorbitan fatty acid ester, (ii) at least 1 conventional pharmaceutical oil contg. a triglyceride as lipophilic component and (iii) at least 1 nonionic surfactant with a HLB value of at least 10.   The active agent is pref. a cyclosporin, rapamycin, tacrolimus, deoxyspergualine, nifedipine, nimodipine, etoposide, ibuprofen or alpha-lipoic acid. The active agent has a solubility, in distilled water, of less than 500mg/1000ml. The active agent concn. is 1-30 wt.%, based on the carrier compsn. The carrier compsn. comprises 10-50 wt.% component (i), 5-40 wt% component (ii) and 10-50 wt % component (iii).
Patent NZ-279773-A (NZ)
Title: Wrapping apparatus; comprises a two-part endless track surrounding a wrapping station; details of the track and of a shuttle which rides around the track and dispenses wrapping material
Inventor: CLEINE KENNETH DAVID
IPC: B65B11/30
Filed: 1995-02-14
Abstract: PCT No. PCT/AU95/00070 Sec. 371 Date Oct. 3, 1996 Sec. 102(e) Date Oct. 3, 1996 PCT Filed Feb. 14, 1995 PCT Pub. No. WO95/21769 PCT Pub. Date Aug. 17, 1995In a wrapping apparatus comprising a two-part endless track surrounding a wrapping station, a shuttle for dispensing wrapping medium able to ride around the track and thereby wrap an article in said station, and a track support structure such that at least one part of the track may be moved relative to another part so as to open and close a gap between those parts, a shuttle change may be effected by providing a movable shuttle carrier in the form of a length of track, and means enabling the shuttle carrier to be inserted into and removed from a gap in the track whereby a replacement shuttle may be driven from the carrier onto the track and a spent shuttle may be driven from the track onto the carrier for removal therewith.
Patent NZ-288880-A (NZ)
Title: Vitamin a preparation; contains stabilised vitamin a/tocopherol mixture; purification of vitamin a; food product containing vitamin a /tocopherol mixture
Inventor: SARAMA ROBERT JOSEPH
IPC: A23L33/155
Filed: 1995-06-09
Abstract: A process for purifying vitamin A consisting of heating a vitamin A preparation in an inert atmosphere, at a temperature below 170 DEG  C. and a pressure of less than 4 mm of mercury, said heating taking place in a vessel shielded from light is disclosed. The vitamin A obtained from this process is mixed with from 0.5:1 to 2:1 parts of tocopherol to vitamin A. The vitamin A and tocopherol mixture can be encapsulated in acacia gum, starch, pectins or other suitable materials. When the vitamin A is encapsulated, the level of tocopherol required is less, preferably from 0.05:1 to about 1:1 parts of tocopherol to vitamin A is used in an encapsulated vitamin A composition. Other antioxidants can be added.
Patent NZ-324615-A (NZ)
Title: Method for treating autism using olanzapine
Inventor: BEASLEY CHARLES M
IPC: A61P25/18
Filed: 1996-12-04
Abstract: The specification describes the use of olanzapine  (US 5,229,382) to treat autism and/or mental retardation
Patent NZ-330835-A (NZ)
Title: Material having a substance protected by deformable standoffs and method of making
Inventor: HAMILTON PETER WORTHINGTON
IPC: C09J7/22
Filed: 1997-01-08
Abstract: A substance delivery system has a three-dimensional structure with outermost surface features (18) and spaces for containing a substance (16). The substance has a level below the outermost surface features such that the substance is protected from inadvertent contact with external surfaces. The substance remains protected until the three-dimensional structure is sufficiently deformed into a substantially two-dimensional structure and the substance is thereby exposed to contact an external surface (20) without compliance of the external surface being necessary. Deforming is preferably achieved by a compression force (F), wherein the outermost surface features (18) of the three-dimensional structure deform in a direction of the compression force. A method of making the three-dimensional material includes the steps of coating a substance onto a forming surface, transferring the coating of substance from the forming surface to a piece of material, and forming the piece of material into a three-dimensional structure on the forming surface while the substance is in contact with the forming surface.
Patent NZ-336732-A (NZ)
Title: Quickly identifying multiple electronic transponders within an area
Inventor: PAGNOL FREDERIC
IPC: G07C9/00
Filed: 1998-12-10
Abstract: A method of identifying a set of transponder situated in the interrogation field of analysis apparatus, with each transponder storing a different identity code. The analysis apparatus (3) transmits data. Each as yet unidentified transponder (1) compares this data with a portion of its own identity code, which portion is selected by the analysis apparatus, and then transmits in a time window that is selected at least as a function of the result of the comparison. The analysis apparatus (3) receives the data transmitted by the transponders (1), and when the data does not enable any of the identity codes thereof to be determined, even in part, it emits a modified data so that after a finite number of iterations it causes each of the transponders to transmit data enabling its identity code to be determined.
Patent NZ-337465-A (NZ)
Title: Pharmaceutical containing erythropoietin and iron preparations for treating haemodialysis patients or anaemias
Inventor: LEHMANN PAUL
IPC: A61K31/715
Filed: 1997-03-18
Abstract: Described is a pharmaceutical combined preparation comprising 250 - 20,000 U of an EPO preparation in an individual form of administration and 5-20 mg of an Fe(III) complex.  The EPO preparation and the Fe(III) complex can be made available in a separate or homogeneous form of administration.  The pharmaceutical preparation is used for treating anaemic or haemodialysis patients.
Patent NZ-337504-A (NZ)
Title: Use of a local anesthetic for increasing fertility or combating infertility
Inventor: EDELSTAM GRETA
IPC: A61K31/167
Filed: 1998-02-09
Abstract: A method for increasing fertility in a woman by 1) administering  a local anesthetic selected from the group consisting of bupivacaine, lidocaine, mepivacaine, prilocaine and ropivacaine and, 2) administering at least 5µg/ml of the anesthetic together with NaCl and a hyaluronan This composition allows for the reduction of spermatozoa phagocytosis, which subsequentially increases the fertility of the woman.
Patent NZ-338050-A (NZ)
Title: Glycidylesters and thermosetting resin composition comprising the glycidylester
Inventor: VAN DOORN JOHANNES ADRIANUS
IPC: C08G59/24
Filed: 1998-05-19
Abstract: A diglycidylester of general formula (I) in which: R1 and R4 are the same or different, C1-C6 alkyl or C6-C10 cycloalkyl groups, and R2 and R3 are the same or different and are H or C1-C6 alkyl or C6-C10 cycloalkyl groups. The diglycidylester is used in a thermosetting resin composition, comprising also a curing compound and preferably an advanced resin product. The thermosetting resin composition can be applied for outdoor durable coatings, having excellent resistance against acid rain.
Patent NZ-502997-A (NZ)
Title: A test strip containing a first and second antibody for a hand-held spectrophotometric type device
Inventor: MCNEIRNEY JOHN C
IPC: G01N33/53
Filed: 1998-08-27
Abstract: A device as shown in Figure 4, for detecting the presence of at least one analyte in a biological sample comprising: (a) A source generating a light beam (170) having one or more predetermined characteristics as to the wavelength of the light beam, the light beam being incident on the biological samples; (b) A light detector receiving an altered light beam from the biological sample, the altered light beam having one or more characteristics as to the wavelength different from one or more predetermined characteristics of the incident light beam, the difference between the characteristics of the wavelength of the incident light beam and the altered light beam being caused by the presence of the biological sample; (c) A processor utilising the difference between the characteristics of the incident light beam (171) and the altered light beam (173) to detect the presence of at least one analyte in the biological sample; and (d) The source, light detector and processor being combined in a hand-held, portable arrangement for providing point-of-care detection of the presence of at least one analyte in the biological sample. A test strip (20) as described in Figure 1a and 1b, comprises an entire analytical matrix (25) having two zones; a first zone (30) serving the function of a "blank" and a second zone (32) being the reactant matrix zone. Zone (32) contains a first antibody in a porous non-reactive carrier matrix (46). The combination of both devices generally relates for detection and quantification of analytes in biological samples.
Patent NZ-504051-A (NZ)
Title: Crystalline polymorphs of 1,3-di-cyclopropylmethyl-8-amino xanthine (cypamfylline), and the use of these compounds for treating PDE4 or TNF mediated diseases
Inventor: EGGLESTON DRAKE
IPC: C07D473/06
Filed: 1998-10-23
Abstract: A crystalline polymorph of 1,3-di-cyclopropylmethyl-8-amino xanthine is described. A pharmaceutical composition comprising this polymorph is also described. The above-described polymorph is useful for treating PDE4 and TNF mediated diseases.
Patent NZ-505177-A (NZ)
Title: Use of milk anti-Inflammatory factor (MAIF) to reduce tissue damage from inflammation
Inventor: BECK LEE R
IPC: A61K35/20
Filed: 1993-09-22
Abstract: A method for preventing neutrophils from adhering to endothelial cells in a non-human mammal, comprising administering to the non-human mammal an anti-inflammatory factor at a dose to prevent the adherence, where the factor is produced by the following process: a) removing the fat from the milk of a milk-producing animal to produce skimmed milk; b) filtering the skimmed milk to retain molecules with molecular weights of greater than 10,000 daltons; c) fractionating the filtrate by ion-exchange chromatography so as to produce ion exchange fractions enriched with the factor; d) purifying the factor by gel filtration; and e) purifying the factor from the gel by affinity chromatography.
Patent NZ-505639-A (NZ)
Title: Process for making 2,4-difluoro-3-Q1-benzoic acid compounds
Inventor: ZHENG XIAOMIN SHARON
IPC: C07C51/363
Filed: 1998-12-28
Abstract: A process for making 5-Q2-6-Q3-2,4-difluoro-3-Q1-benzoic acid represented by formula (I), wherein Q1 is derived from an electrophilic reagent, comprising the steps of: a)  treating 1-bromo-2,4-difluorobenzene with a strong, non-nucleophilic base; then treating with an electrophilic reagent which provides Q1 or a functional moiety which is then transformed to Q1, producing 1-bromo-2,4-difluoro-3-Q1-benzene b)  treating the 1-bromo-2,4-difluoro-3-Q1-benzene with an alkali or alkaline earth metal or organometallic reagent; then treating with carbon dioxide, or with a formylating agent followed by oxidation, to produce 2,4-difluoro-3-Q1-benzoic acid; c)  incorporating a non-hydrogen Q2 or Q3 moiety to said 2,4-difluoro-3-Q1-benzoic acid, wherein Q2 and Q3 may be the same non-hydrogen moiety with additional reaction step.
Patent NZ-505994-A (NZ)
Title: Statin-matrix metalloproteinase inhibitor combinations useful fro treating vascular diseases
Inventor: NEWTON ROGER SCHOFIELD
IPC: A61K31/22
Filed: 1998-11-20
Abstract: A pharmaceutical composition contains: a MMP inhibitor or a salt thereof of formula (I) wherein A is phenyl, piperidinyl or piperazinyl; R1 is alkyl, aryl, halo, optionally substituted amino or alkoxy and R2 is carboxyalkyl ketone, carboxyalkyl sulphonamide or oxime; a statin or a salt thereof and a pharmaceutically carrier or diluent. The MMP inhibitor of formula (I) is used in the manufacture of a medicament to treat hyperlipidemia.
Patent NZ-507754-A (NZ)
Title: Dishwasher with multiple independent claims
Inventor: MAUNSELL STEVE
IPC: A47L15/00
Filed: 1998-01-30
Abstract: In order to resist racking forces rigid link members 67,68 transfer racking forces to the gusseted area 209 adjacent to recessed kick plate 62.
Patent NZ-512754-A (NZ)
Title: Remedial agent for erectile dysfunction containing a 3(2H)-pyridazinone derivative
Inventor: YAMASHITA TORU
IPC: A61K31/50
Filed: 1999-11-30
Abstract: 3(2H)-pyridazinone derivative of formula (I) is used for treating erectile dysfunction, where R1 represents a hydrogen atom, a C1-4 alkyl group, a C3-4 alkenyl group or (CH2)nCO2R5, n represents an integer of 1 to 4 and R5 represents a hydrogen atom or a C1-4 alkyl group; R2 represents a hydrogen atom or a C1-4 alkyl group; R3 and R4 each independently represent a hydrogen atom or a C1-3 alkyl group; A represents a single bond or a straight or branched C1-11 alkylene in which a carbon atom on the straight chain may be substituted by one OR2 group; X represents a chlorine atom, a bromine atom, a hydrogen atom or a cyano group; Y represents a thienyl group, (5) a pyridyl group, a cyano group, CO2R5, OR6 where R6 represents a hydrogen atom, a C1-4 alkyl group or a phenyl group.
Patent NZ-514633-A (NZ)
Title: Camera having a barrier assembly comprising an integrated lens cover/light hood
Inventor: BITTNER WILFRIED
IPC: G03B17/02
Filed: 2000-04-25
Abstract: A camera has a barrier assembly (16) that comprises an integrated lens over/light hood (17), and a rotatable door (18). The assembly is movable between an open and a closed position. The assembly functions as a protective barrier for the camera's picture- taking lens (13) when disposed in the closed position. The door is located within an aperture (19) defined by the lens cover/light hood when the assembly is closed. The door rotates away from the aperture as the assembly translates to the open position. The aperture is substantially aligned with the optical axis (14) of the picture-taking lens as the assembly reaches its open position, thereby allowing ambient light to reach the picture-taking lens. The lens cover/light hood isolates the lens from ambient light outside the field of view of the lens when the assembly is in its open position.
Patent NZ-525122-A (NZ)
Title: Snug fitting floating eyewear
Inventor: BONACCI THOMAS A
IPC: A61F9/02
Filed: 2003-04-02
Abstract: Floating eyewhere hat fits snugly to a users face, comprising, a frame having a middle bridge with lenses on either side of the frame. Two temples on either side of the frame with at least one opening therethrough Each temple has a n inner and outer surface. The outer surface having a convex shape in order to fit around the head. Each side temple is fixed to the frame via hinges which allow them to be folded against the frame for easy storage and handling. Resilient float pads are fitted within the openings, wherein the pads engagement with the wearers head creates a snug fit and said pad having sufficient buoyancy to overcome the combined weight of the frame and temples permitting the eye where to float in the water.
Patent NZ-525144-A (NZ)
Title: Substituted 4-phenyl-1-(1-phenyl-cyclohexyl)-1,2,3,6-tetrahydropyridine
Inventor: CHIZH BORIS
IPC: A61P25/28
Filed: 2001-09-05
Abstract: Substituted 4-phenyl-1-(1-phenyl-cyclohexyl)-1,2,3,6-tetrahydropyridine, a method for the production thereof, pharmaceuticals containing said compounds, and the use of the same for producing pharmaceuticals.
Patent NZ-525631-A (NZ)
Title: Pravastatin sodium substantially free of pravastatin lactone and epi-pravastatin, and compositions containing same
Inventor: KERI VILMOS
IPC: A61K31/22
Filed: 2001-10-05
Abstract: Substantially pure pravastatin sodium substantially free of pravastatin lactone and epiprava, the C-6 epimer of pravastatin is disclosed. A process for recovering pravastatin sodium from a fermentation broth in such high purity is also disclosed, wherein the process includes the stages of forming an solution of the compound by extraction, obtaining an ammonium salt of pravastatin from the solution, purifying the ammonium salt of the compound and transposing the salt of the compound to pravastatin sodium.
Patent NZ-526334-A (NZ)
Title: Sensor with integrated lancet for monitoring blood by colorometric or electrochemical test method
Inventor: VREEKE MARK S
IPC: G01N27/416
Filed: 2003-06-06
Abstract: A fluid collection apparatus to test a concentration of an analyte in a fluid and a method of testing a concentration of glucose in a user's blood is disclosed, wherein the apparatus comprises: a lid; a base having a plane; a spacer disposed between the lid and base, wherein the spacer includes a capillary channel having an opening for receiving the fluid; and a lance disposed between the lid and the base, the lance is movable relative to the base and parallel to the plane of the base, the lance has a piercing end that is movable to a position adjacent the opening of the capillary channel, the lance extends beyond the lid and the base for puncturing. A colorimetric test device, an electrochemical test device or a test device adapted to measure the absorption of infrared light by the fluid may be used in combination with this fluid collection apparatus.
Patent NZ-537436-A (NZ)
Title: Metastable pharmaceutical compositions
Inventor: WILKINS NINA FRANCES
IPC: A61K9/70
Filed: 2003-06-24
Abstract: Disclosed is a pharmaceutical composition for transdermal delivery comprising; one or more physiologically active agents; and a volatile pharmaceutically acceptable solvent; wherein the composition is substantially free of non-volatile penetration enhancers and wherein the physiologically active agent and the volatile solvent provide a metastable deposit comprising the physiologically active agent upon evaporation of the volatile solvent.
Patent NZ-537678-A (NZ)
Title: Total synthesis of myriaporones
Inventor: PEREZ ALVAREZ MARTA
IPC: C07D493/08
Filed: 2003-07-30
Abstract: Disclosed are compounds of formula (I) and methods of producing them, wherein: R is each independently H, SiR'3, SOR', SO2R', C(=O)R', C(=O)OR', C(=O)NR', optionally substituted alkyl, alkenyl, alkynyl, aryl, heteroaryl or aralkyl, R'' is H, OH, OR', OCOR', SH, SR', SOR', SO2R', NO2, NH2, NHR', N(R')2, NHCOR', N(COR')2, NHSO2R', CN, halogen, C(=O)H, C(=O)R', CO2H, CO2R', CH2OR optionally substituted alkyl, haloalkyl, alkenyl, alkylidene, alkynyl, aryl, aralkyl, or heteroaromatic. The compounds are used for the manufacture of medicaments for the treatment of cancer.
Patent NZ-537902-A (NZ)
Title: Improvements relating to radio communication systems
Inventor: BUSCH A D
IPC: H04Q7/38
Filed: 2002-08-08
Abstract: A communication system utilizes a local area network where the network includes a first node with a first clock and a second node with a second clock to synchronize the first and second clocks. The first node is adapted to send a first synchronization message to the second node at a first time according to the clock of the first node. The second node is adapted to send a second synchronization message to the first node at a second time according to the clock of the second node. One node is adapted to determine a first difference as the difference between the time on the first clock when the first message was sent and the time on the second clock when the first message was received. One node is adapted to determine a second difference as the difference between the time on the second clock then the second message was sent and the time on the first clock when the second message was received. One node is adapted to determine a clock error as the average of the difference between the first and second differences, and adjusting the clock of either the first node or the second node by the clock error. (62) Divided out of 520650